Effect of Therapy on CML (PDF), a paper about measuring the effect of therapy on CMLPlease find below a list of useful resources. Please note, some resources are in PDF format and Adobe® Reader®, may be required to download, view, and print PDF files (Adobe® Reader® is available to download for free from Adobe).
Effect of Therapy on CML (PDF), a paper about measuring the effect of therapy on CML
CML Molecular Target animation, a short animation on CML
The animation can be viewed with Apple Quicktime. At 56kbps, download time is estimated at about 25 minutes.
Second-Generation Tyrosine Kinase Inhibitors in the Treatment of Patients With Imatinib-Resistant Mutations
Francis J. Giles, MD
Cancer Therapy and Research Center
University of Texas Health Science Center
San Antonio, Texas
Safety and Efficacy of Second-Generation Tyrosine Kinase Inhibitors in Imatinib-Resistant and Intolerant CML
Michele Baccarani, MD
S.Orsola-Malpighi Hospital
University of Bologna
Bologna, Italy
Imatinib in Chronic Phase CML: Safe, Effective After 5 Years
Hagop Kantarjian, MD
M.D.Anderson Cancer Center
University of Texas
Houston, Texas
Imatinib Dose Escalation Shows Enhanced Efficacy in Chronic Phase CML
Timothy Hughes, MD, MBBS
Institute of Medical and Veterinary Science
University of Adelaide
Adelaide, Australia
CML patient brochure (PDF), a brochure about the human impact of Glivec on CML
Developed in partnership with Novartis Oncology by EPG Online